Tuberculin, solution for injection, 2 IU/dose/0.1 ml, 1 ml per vial (Tuberculin PPD-L solution for injection with activity 2 IU/dose; 1 ml (10 doses) in ampoules No. 10 according to DK 021:2015: 33650000-1 General anti-infective agents for systemic use, vaccines, antineoplastic and immunomodulatory drugs; MNN: Tuberculin; ATC code V04CF01)

This tender seeks the supply of Tuberculin PPD-L solution for injection, specifically at a concentration of 2 IU per dose (0.1 ml), packaged in 1 ml ampoules (10 doses per ampoule). The procurement falls under CPV code 33650000-1, which covers general anti-infective agents for systemic use, vaccines, antineoplastic drugs, and immunomodulatory drugs. The MNN (International Nonproprietary Name) is Tuberculin, and the ATC code is V04CF01. A key condition of this tender is that the country of origin for the supplied product cannot be the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran. The delivery of the tuberculin will be in batches to the customer's location at 43 Kobylyanska Street, Sokyriany, Chernivtsi region, with a deadline of December 25, 2026. All transportation costs, including loading and unloading, and delivery to the customer's warehouse are the responsibility of the supplier. The procuring entity is the Communal Non-Profit Enterprise "Sokyriany Center for Primary Healthcare".

This is a supplies contract in the health and medical services sector, with a focus on Primary Healthcare. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 26,500.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.